Article info
Correspondence
Ustekinumab inhibits Th1 and Th17 polarisation in a patient with giant cell arteritis
- Correspondence to Pr Bernard Bonnotte, Department of Internal Medicine and Clinical Immunology, François Mitterrand Hospital, Dijon University Hospital, 21000 Dijon, France; bernard.bonnotte{at}chu-dijon.fr
Citation
Ustekinumab inhibits Th1 and Th17 polarisation in a patient with giant cell arteritis
Publication history
- Received April 10, 2017
- Accepted April 13, 2017
- First published May 13, 2017.
Online issue publication
January 12, 2018
Article Versions
- Previous version (13 May 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.